PTSD Trial, Recruiting NCT06947538 Sponsor: Boston Medical Center Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT06947538
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who receive primary care at Boston Medical Center
  • People who are at least 18 years old
  • People who have access to a computer or mobile device
  • People who are able to receive treatment in English or Spanish
  • People who can read at around a 4th grade level
  • People who have experienced a traumatic event, confirmed using a standard checklist at the baseline appointment
  • People who have been diagnosed with PTSD, confirmed by a clinician using a standard assessment at the baseline appointment
  • People whose condition is considered appropriate for outpatient care (treatment without hospital admission)
  • People who have been on psychiatric medication (if any) at a stable dose for more than 4 weeks

Who may not be able to join:

  • People who are currently receiving therapy provided by a clinician
  • People whose condition is not considered appropriate for outpatient care, as assessed by a clinician at the baseline appointment
  • People who are assessed as having an immediate or serious risk of suicidal thoughts or behaviour, as determined by a clinician using a standard rating scale at the baseline appointment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sarah Valentine, PhD, Boston Medical Center, Psychiatry

Phone: 857 264 1102

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Boston Medical Center
Registry
ClinicalTrials.gov
Start date
12 March 2026
Est. completion
1 June 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

PTSD symptom severity; Treatment retention; Treatment acceptability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov